Sequoia Financial Advisors LLC Has $751,000 Stake in The Clorox Company (NYSE:CLX)

Sequoia Financial Advisors LLC lifted its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 9.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,624 shares of the company’s stock after purchasing an additional 396 shares during the period. Sequoia Financial Advisors LLC’s holdings in Clorox were worth $751,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of CLX. Ilex Capital Partners UK LLP lifted its position in shares of Clorox by 512.7% during the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock worth $88,315,000 after purchasing an additional 453,624 shares in the last quarter. Amundi lifted its position in shares of Clorox by 42.6% during the fourth quarter. Amundi now owns 1,032,283 shares of the company’s stock worth $165,816,000 after purchasing an additional 308,234 shares in the last quarter. Assenagon Asset Management S.A. lifted its position in shares of Clorox by 302.0% during the fourth quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock worth $57,390,000 after purchasing an additional 265,455 shares in the last quarter. State Street Corp lifted its position in shares of Clorox by 3.1% during the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after purchasing an additional 245,525 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in shares of Clorox during the fourth quarter worth approximately $37,935,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on CLX shares. Barclays boosted their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 5th. Wells Fargo & Company boosted their price target on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. DA Davidson dropped their price target on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 price target on shares of Clorox in a research note on Thursday, January 30th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, Clorox currently has an average rating of “Hold” and an average target price of $159.62.

Check Out Our Latest Analysis on Clorox

Clorox Price Performance

CLX stock opened at $147.32 on Monday. The stock has a 50-day moving average price of $154.20 and a two-hundred day moving average price of $160.23. The stock has a market cap of $18.15 billion, a PE ratio of 40.25, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37.

Clorox (NYSE:CLXGet Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the firm posted $2.16 earnings per share. Equities analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.31%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox’s payout ratio is 133.33%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.